| Net Loss | -1.48M |
| Depreciation, Depletion & Amortization | 234.15K |
| Impairment, Dry Hole & Other Disposals of Property | 24.64K |
| Stock Option Expense | |
| Warrant Expense | |
| (Gain) on Sale of Property | |
| Director Stock Compensation | |
| (Increase) in Accounts Receivable | 115.44K |
| (Increase) or Decrease in Deposits, Prepaids & Other Assets | |
| (Increase) or Decrease in Accounts Receivable from Joint Venture Partners | |
| (Decrease) in Accounts Payable, Deferred Revenue & Accrued Expenses | |
| Net Cash Used in Operating Activities | -416.54K |
| Proceeds from the Sale of Property | 0 |
| Capital Expenditures | -191.09K |
| (Investment in) Marketable Securities | |
| Net Cash Used by Investing Activities | -144.54K |
| Principal Payments on Long-Term Debt | -12.26K |
| (Purchase) of Treasury Stock | |
| Net Proceeds from the Issuance of Stock Options | |
| Net Proceeds from the Issuance of Common Stock | |
| Net Cash Provided by Financing Activities | -12.26K |
| Net Increase in Cash and Cash Equivalents | -573.33K |
| Cash at the Beginning of Period | 584.42K |
| Cash at the End of Period | 11.08K |